184 related articles for article (PubMed ID: 22120515)
1. Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population.
Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
Med Oncol; 2012 Dec; 29(4):2445-51. PubMed ID: 22120515
[TBL] [Abstract][Full Text] [Related]
2. The association between the Survivin A9194G exon polymorphisms and papillary thyroid carcinoma risk in the Han Chinese population.
Wang YX; Li ML; Yu SG; Liu CM; Han Y; Wang XY
Pathol Res Pract; 2013 Mar; 209(3):151-4. PubMed ID: 23414714
[TBL] [Abstract][Full Text] [Related]
3. Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population.
Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
Endocrine; 2012 Jun; 41(3):526-31. PubMed ID: 22194161
[TBL] [Abstract][Full Text] [Related]
4. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
[TBL] [Abstract][Full Text] [Related]
5. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
Dong G; Zhang R; Xu J; Guo Y
Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
[TBL] [Abstract][Full Text] [Related]
6. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population.
Wei WJ; Lu ZW; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
Int J Mol Sci; 2014 Nov; 15(11):20968-81. PubMed ID: 25405731
[TBL] [Abstract][Full Text] [Related]
7. [Study on genetic polymorphism of human mismatch repair gene hMLH1 and susceptibility of papillary thyroid carcinoma in Chinese Han people].
Shi WP; Bian JC; Jiang F; Ni HX; Zhu QX; Tang HW; Shen Q; Wu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Mar; 44(3):235-41. PubMed ID: 20450746
[TBL] [Abstract][Full Text] [Related]
8. Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer.
Liamarkopoulos E; Gazouli M; Aravantinos G; Tzanakis N; Theodoropoulos G; Rizos S; Nikiteas N
Gastric Cancer; 2011 Oct; 14(4):317-21. PubMed ID: 21461653
[TBL] [Abstract][Full Text] [Related]
9. Association between a functional insertion/deletion polymorphism in IL1A gene and risk of papillary thyroid carcinoma.
Gao L; Zhu X; Li Z; Li L; Wang T; Hu H; Guo W; Chen P; Zhu J; Zhang L
Tumour Biol; 2014 Apr; 35(4):3861-5. PubMed ID: 24453029
[TBL] [Abstract][Full Text] [Related]
10. Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?
Ai L; Yu Y; Liu X; Wang C; Shi J; Sun H; Yu Q
Front Med; 2014 Mar; 8(1):113-7. PubMed ID: 24452548
[TBL] [Abstract][Full Text] [Related]
11. Correlation between polymorphisms of BRAF gene and papillary thyroid carcinoma.
Jiang R; Zhao C; Xu H; Zhao M; Sun X; Wang X; Song W
Clin Endocrinol (Oxf); 2016 Mar; 84(3):431-7. PubMed ID: 25916409
[TBL] [Abstract][Full Text] [Related]
12. Correlation between
Zhang F; Fan G; Wang X
Biomark Med; 2022 May; 16(7):537-547. PubMed ID: 35362324
[No Abstract] [Full Text] [Related]
13. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.
Gangwar R; Mandhani A; Mittal RD
Ann Surg Oncol; 2009 Jul; 16(7):2028-34. PubMed ID: 19412632
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.
Çil E; Kumral A; Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Altuntaş Y; Uysal M
Mol Biol Rep; 2014 May; 41(5):3091-7. PubMed ID: 24464184
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis.
Theodoropoulos GE; Gazouli M; Vaiopoulou A; Leandrou M; Nikouli S; Vassou E; Kouraklis G; Nikiteas N
Int J Colorectal Dis; 2011 Sep; 26(9):1113-8. PubMed ID: 21538054
[TBL] [Abstract][Full Text] [Related]
16. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
[TBL] [Abstract][Full Text] [Related]
17. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
[TBL] [Abstract][Full Text] [Related]
18. Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma.
Nie X; Yuan F; Chen P; Pu Y; Zhu J; Wang Y; Xiao X; Che G; Gao L; Zhang L
Biomark Med; 2017 Feb; 11(2):141-149. PubMed ID: 27929666
[TBL] [Abstract][Full Text] [Related]
19. OPN -443C>T genetic polymorphism and tumor OPN expression are associated with the risk and clinical features of papillary thyroid cancer in a Chinese cohort.
Mu G; Wang H; Cai Z; Ji H
Cell Physiol Biochem; 2013; 32(1):171-9. PubMed ID: 23867349
[TBL] [Abstract][Full Text] [Related]
20. A cyclin D1 (CCND1) gene polymorphism contributes to susceptibility to papillary thyroid cancer in the Turkish population.
Aytekin T; Aytekin A; Maralcan G; Gokalp MA; Ozen D; Borazan E; Yilmaz L
Asian Pac J Cancer Prev; 2014; 15(17):7181-5. PubMed ID: 25227811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
